Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

17-12-2022 | Original Paper

Use of ECT in Autism Spectrum Disorder and/or Intellectual Disability: A Single Site Retrospective Analysis

Auteurs: Joshua R. Smith, Corey E. Hopkins, Jiangmei Xiong, James Luccarelli, Elizabeth Shultz, Simon Vandekar

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 3/2024

Abstract

Autism spectrum disorder (ASD) and intellectual disability (ID) are heterogenous and prevalent conditions which may occur in isolation or as a co-morbidity. Psychiatric co-morbidity is common with limited treatment options. Preliminary research into electroconvulsive therapy (ECT) for these conditions has been encouraging. Thus, further research in this patient population is warranted. We conducted a 10-year retrospective review of the electronic medical record and identified intellectually capable individuals with ASD (IC-ASD), and those with ASD+ID or ID who received at least three ECT treatments. 32 patients were identified of which 30 (94%) experienced positive clinical response, defined as a clinical global impression-improvement (CGI-I) score of 3 or less. The average retrospective CGI-I score across all groups was 1.97, and results of a t-test performed on CGI-I scores indicated improvement across all groups [t = − 16.54, df = 31, p < 0.001, 95% CI = (1.72, 2.22)]. No significant adverse events were identified based on clinical documentation. Our findings further support previous ECT research in this patient population.

vorige artikel Male and Female Toddlers with DSM-5 Autism Spectrum Disorder have Similar Developmental Profiles and Core Autism Symptoms

volgende artikel Caregiver Attributions of Toddlers’ Behaviors: A Comparison Between Groups of Children with Differing Developmental Concerns

Alleen toegankelijk voor geautoriseerde gebruikers

Adıgüzel Akman, Ö., Kahraman Girgeç, S., Çelik, S., Çakır Kardeş, V., & Atasoy, N. (2021). Maintenance electroconvulsive therapy for agitation and self injurious behaviors in autism spectrum disorder. Turkish Journal of Psychiatry, 32(1), 65–69. https://doi.org/10.5080/u23768CrossRefPubMed

Alfageh, B. H., Wang, Z., Mongkhon, P., Besag, F. M. C., Alhawassi, T. M., Brauer, R., & Wong, I. C. K. (2019). Safety and tolerability of antipsychotic medication in individuals with autism spectrum disorder: A systematic review and meta-analysis. Pediatric Drugs, 21(3), 153–167. https://doi.org/10.1007/s40272-019-00333-xCrossRefPubMed

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). American Psychiatric Publishing: Arlington. https://doi.org/10.1176/appi.books.9780890425596CrossRef

Bahji, A., Hawken, E. R., Sepehry, A. A., Cabrera, C. A., & Vazquez, G. (2019). ECT beyond unipolar major depression: Systematic review and meta-analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatrica Scandinavica, 139(3), 214–226. https://doi.org/10.1111/acps.12994CrossRefPubMed

Becker, J. E., Smith, J. R., & Hazen, E. P. (2020). Pediatric consultation-liaison psychiatry: An update and review. Psychosomatics, 61(5), 467–480. https://doi.org/10.1016/j.psym.2020.04.015CrossRefPubMedPubMedCentral

Benarous, X., Consoli, A., Raffin, M., Bodeau, N., Giannitelli, M., Cohen, D., & Olliac, B. (2016). Validation of the Pediatric Catatonia Rating Scale (PCRS). Schizophrenia Research, 176(2–3), 378–386. https://doi.org/10.1016/j.schres.2016.06.020CrossRefPubMed

Bush, G., Fink, M., Petrides, G., Dowling, F., & Francis, A. (1996). Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica, 93(2), 129–136. https://doi.org/10.1111/j.1600-0447.1996.tb09814.xCrossRefPubMed

Busner, J., & Targum, S. D. (2007). The clinical global impressions scale. Psychiatry (Edgmont), 4(7), 28–37.PubMed

Buzsáki, G., & Wang, X.-J. (2012). Mechanisms of gamma oscillations. Annual Review of Neuroscience, 35(1), 203–225. https://doi.org/10.1146/annurev-neuro-062111-150444CrossRefPubMedPubMedCentral

Carroll, B. T., Kirkhart, R., Ahuja, N., Soovere, I., Lauterbach, E. C., Dhossche, D., & Talbert, R. (2008). Katatonia: A new conceptual understanding of catatonia and a new rating scale. Psychiatry (Edgmont), 5(12), 42–50.PubMed

Casanova, M. F., Shaban, M., Ghazal, M., El-Baz, A. S., Casanova, E. L., Opris, I., & Sokhadze, E. M. (2020). Effects of transcranial magnetic stimulation therapy on evoked and induced gamma oscillations in children with autism spectrum disorder. Brain Sciences, 10(7), 423. https://doi.org/10.3390/brainsci10070423CrossRefPubMedPubMedCentral

Castaneda-Ramirez, S., Becker, T. D., Bruges-Boude, A., Kellner, C., & Rice, T. R. (2022). Systematic review: Electroconvulsive therapy for treatment-resistant mood disorders in children and adolescents. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-022-01942-7CrossRef

Christensen, D. L. (2019). Prevalence and characteristics of autism spectrum disorder among children aged 4 years—Early autism and developmental disabilities monitoring network, seven sites, United States, 2010, 2012, and 2014. MMWR. Surveillance Summaries. https://doi.org/10.15585/mmwr.ss6802a1CrossRefPubMedCentral

Consoli, A., Cohen, J., Bodeau, N., Guinchat, V., Wachtel, L., & Cohen, D. (2013). Electroconvulsive therapy in adolescents with intellectual disability and severe self-injurious behavior and aggression: A retrospective study. European Child & Adolescent Psychiatry, 22(1), 55–62. https://doi.org/10.1007/s00787-012-0320-7CrossRef

Consoli, A., Raffin, M., Laurent, C., Bodeau, N., Campion, D., Amoura, Z., Sedel, F., An-Gourfinkel, I., Bonnot, O., & Cohen, D. (2012). Medical and developmental risk factors of catatonia in children and adolescents: A prospective case-control study. Schizophrenia Research, 137(1–3), 151–158. https://doi.org/10.1016/j.schres.2012.02.012CrossRefPubMed

DeJong, H., Bunton, P., & Hare, D. J. (2014). A systematic review of interventions used to treat catatonic symptoms in people with autistic spectrum disorders. Journal of Autism and Developmental Disorders, 44(9), 2127–2136. https://doi.org/10.1007/s10803-014-2085-yCrossRefPubMed

Desarkar, P., Blumberger, D., & Daskalakis, Z. J. (2018). Case report: Successful use of the combination of electroconvulsive therapy and clozapine in treating treatment-resistant schizophrenia and catatonia in an adult with intellectual disability. Journal of Autism and Developmental Disorders, 48(10), 3637–3640. https://doi.org/10.1007/s10803-018-3589-7CrossRefPubMed

Dodd, P., Doherty, A., & Guerin, S. (2016). A systematic review of suicidality in people with intellectual disabilities. Harvard Review of Psychiatry, 24(3), 202–213. https://doi.org/10.1097/HRP.0000000000000095CrossRefPubMed

Dunn, K., Rydzewska, E., Fleming, M., & Cooper, S.-A. (2020). Prevalence of mental health conditions, sensory impairments and physical disability in people with co-occurring intellectual disabilities and autism compared with other people: A cross-sectional total population study in Scotland. British Medical Journal Open, 10(4), e035280. https://doi.org/10.1136/bmjopen-2019-035280CrossRef

Eaton, C., Tarver, J., Shirazi, A., Pearson, E., Walker, L., Bird, M., Oliver, C., & Waite, J. (2021). A systematic review of the behaviours associated with depression in people with severe–profound intellectual disability. Journal of Intellectual Disability Research, 65(3), 211–229. https://doi.org/10.1111/jir.12807CrossRefPubMed

Epic SlicerDicer. (2021). EPIC Systems Corporation. https://www.epic.com/about

Espinoza, R. T., & Kellner, C. H. (2022). Electroconvulsive therapy. New England Journal of Medicine, 386(7), 667–672. https://doi.org/10.1056/NEJMra2034954CrossRefPubMed

Hashemi, E., Ariza, J., Rogers, H., Noctor, S. C., & Martínez-Cerdeño, V. (2017). The Number of parvalbumin-expressing interneurons is decreased in the prefrontal cortex in autism. Cerebral Cortex (New York, N.Y.: 1991), 27(3), 1931–1943. https://doi.org/10.1093/cercor/bhw021CrossRefPubMed

Hedley, D., & Uljarević, M. (2018). Systematic review of suicide in autism spectrum disorder: Current trends and implications. Current Developmental Disorders Reports, 5(1), 65–76. https://doi.org/10.1007/s40474-018-0133-6CrossRef

Hellsten, J., Wennström, M., Mohapel, P., Ekdahl, C. T., Bengzon, J., & Tingström, A. (2002). Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment. European Journal of Neuroscience, 16(2), 283–290. https://doi.org/10.1046/j.1460-9568.2002.02093.xCrossRefPubMed

Henneberry, E., Lamy, M., Dominick, K. C., & Erickson, C. A. (2021). Decades of progress in the psychopharmacology of autism spectrum disorder. Journal of Autism and Developmental Disorders, 51(12), 4370–4394. https://doi.org/10.1007/s10803-021-05237-9CrossRefPubMed

Hepburn, S. L., Stern, J. A., Blakeley-Smith, A., Kimel, L. K., & Reaven, J. A. (2014). Complex psychiatric comorbidity of treatment-seeking youth with autism spectrum disorder and anxiety symptoms. Journal of Mental Health Research in Intellectual Disabilities, 7(4), 359–378. https://doi.org/10.1080/19315864.2014.932476CrossRefPubMedPubMedCentral

Horowitz, L. M., Thurm, A., Farmer, C., Mazefsky, C., Lanzillo, E., Bridge, J. A., Greenbaum, R., Pao, M., Siegel, M., Autism and Developmental Disorders Inpatient Research Collaborative (ADDIRC). (2018). Talking about death or suicide: prevalence and clinical correlates in youth with autism spectrum disorder in the psychiatric inpatient setting. Journal of Autism and Developmental Disorders, 48(11), 3702–3710. https://doi.org/10.1007/s10803-017-3180-7CrossRefPubMedPubMedCentral

Howlin, P., Goode, S., Hutton, J., & Rutter, M. (2004). Adult outcome for children with autism. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 45(2), 212–229. https://doi.org/10.1111/j.1469-7610.2004.00215.xCrossRefPubMed

Hutton, J. (2008). New-onset psychiatric disorders in individuals with autism. Autism, 12(4), 373–390.CrossRefPubMed

Inta, D., Lima-Ojeda, J. M., Lau, T., Tang, W., Dormann, C., Sprengel, R., Schloss, P., Sartorius, A., Meyer-Lindenberg, A., & Gass, P. (2013). Electroconvulsive therapy induces neurogenesis in frontal rat brain areas. PLoS ONE, 8(7), e69869. https://doi.org/10.1371/journal.pone.0069869ADSCrossRefPubMedPubMedCentral

Iwase, S., Bérubé, N. G., Zhou, Z., Kasri, N. N., Battaglioli, E., Scandaglia, M., & Barco, A. (2017). Epigenetic etiology of intellectual disability. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 37(45), 10773–10782. https://doi.org/10.1523/JNEUROSCI.1840-17.2017CrossRefPubMed

Jannati, A., Block, G., Ryan, M. A., Kaye, H. L., Kayarian, F. B., Bashir, S., Oberman, L. M., Pascual-Leone, A., & Rotenberg, A. (2020). Continuous theta-burst stimulation in children with high-functioning autism spectrum disorder and typically developing children. Frontiers in Integrative Neuroscience, 14, 13. https://doi.org/10.3389/fnint.2020.00013CrossRefPubMedPubMedCentral

Jeste, S. S., & Nelson, C. A. (2009). Event related potentials in the understanding of autism spectrum disorders: An analytical review. Journal of Autism and Developmental Disorders, 39(3), 495. https://doi.org/10.1007/s10803-008-0652-9CrossRefPubMed

Johnston, N. E. (2015). Delays in accessing electroconvulsive therapy: A comparison between two urban and two rural populations in Australia. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists, 23(5), 566–570. https://doi.org/10.1177/1039856215597540CrossRefPubMed

Kellner, C. H., Knapp, R., Husain, M. M., Rasmussen, K., Sampson, S., Cullum, M., McClintock, S. M., Tobias, K. G., Martino, C., Mueller, M., Bailine, S. H., Fink, M., & Petrides, G. (2010). Bifrontal, bitemporal and right unilateral electrode placement in ECT: Randomised trial. The British Journal of Psychiatry: The Journal of Mental Science, 196(3), 226–234. https://doi.org/10.1192/bjp.bp.109.066183CrossRefPubMed

Lazoff, T., Zhong, L., Piperni, T., & Fombonne, E. (2010). Prevalence of pervasive developmental disorders among children at the english montreal school board. The Canadian Journal of Psychiatry, 55(11), 715–720. https://doi.org/10.1177/070674371005501105CrossRefPubMed

Lee, E., Lee, J., & Kim, E. (2017). Excitation/inhibition imbalance in animal models of autism spectrum disorders. Biological Psychiatry, 81(10), 838–847. https://doi.org/10.1016/j.biopsych.2016.05.011CrossRefPubMed

Lord, C., Charman, T., Havdahl, A., Carbone, Paul, Anagnostou, E., Boyd, Brian, Carr, T., de Vries, P. J., Dissanayake, C., Divan, G., Freitag, C. M., Gotelli, M. M., Kasari, C., Knapp, M., Mundy, P., Plank, A., Scahill, L., Servili, C., Shattuck, P., … McCauley, J. B. (2022). The Lancet Commission on the future of care and clinical research in autism. The Lancet, 399(10321), 271–334. https://doi.org/10.1016/S0140-6736(21)01541-5CrossRef

Luccarelli, J., Henry, M. E., & McCoy, T. H. (2020a). Quantification of fracture rate during electroconvulsive therapy (ECT) using state-mandated reporting data. Brain Stimulation, 13(3), 523–524. https://doi.org/10.1016/j.brs.2019.12.007CrossRefPubMed

Luccarelli, J., Henry, M. E., & McCoy, T. H. (2020b). Demographics of patients receiving electroconvulsive therapy based on state-mandated reporting data. The Journal of ECT, 36(4), 229–233. https://doi.org/10.1097/YCT.0000000000000692CrossRefPubMedPubMedCentral

Luccarelli, J., Kalinich, M., Fernandez-Robles, C., Fricchione, G., & Beach, S. R. (2022). The incidence of catatonia diagnosis among pediatric patients discharged from general hospitals in the United States: A kids’ inpatient database study. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2022.878173CrossRefPubMedPubMedCentral

Luccarelli, J., McCoy, T. H., Seiner, S. J., & Henry, M. E. (2021a). Real-world evidence of age-independent electroconvulsive therapy efficacy: A retrospective cohort study. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.13378CrossRefPubMedPubMedCentral

Luccarelli, J., McCoy, T. H., Uchida, M., Green, A., Seiner, S. J., & Henry, M. E. (2021b). The Efficacy and cognitive effects of acute course electroconvulsive therapy are equal in adolescents, transitional age youth, and young adults. Journal of Child and Adolescent Psychopharmacology, 31(8), 538–544. https://doi.org/10.1089/cap.2021.0064CrossRefPubMedPubMedCentral

Ludi, E., Ballard, E. D., Greenbaum, R., Pao, M., Bridge, J., Reynolds, W., & Horowitz, L. (2012). Suicide Risk in youth with intellectual disability: The challenges of screening. Journal of Developmental and Behavioral Pediatrics : JDBP, 33(5), 431–440. https://doi.org/10.1097/DBP.0b013e3182599295CrossRefPubMed

Maenner, M. J. (2020). Prevalence of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network, 11 sites, United States, 2016. MMWR. Surveillance Summaries. https://doi.org/10.15585/mmwr.ss6904a1CrossRefPubMedCentral

Maulik, P. K., Mascarenhas, M. N., Mathers, C. D., Dua, T., & Saxena, S. (2011). Prevalence of intellectual disability: A meta-analysis of population-based studies. Research in Developmental Disabilities, 32(2), 419–436. https://doi.org/10.1016/j.ridd.2010.12.018CrossRefPubMed

Mazza, M. G., Rossetti, A., Crespi, G., & Clerici, M. (2020). Prevalence of co-occurring psychiatric disorders in adults and adolescents with intellectual disability: A systematic review and meta-analysis. Journal of Applied Research in Intellectual Disabilities: JARID, 33(2), 126–138. https://doi.org/10.1111/jar.12654CrossRefPubMed

McFayden, T. C., Gatto, A. J., Dahiya, A. V., Antezana, L., Miyazaki, Y., & Cooper, L. D. (2021). Integrating measurement-based care into treatment for autism spectrum disorder: Insights from a community clinic. Journal of Autism and Developmental Disorders, 51(10), 3651–3661. https://doi.org/10.1007/s10803-020-04824-6CrossRefPubMed

Miller, J., Sowar, K., Abbott, C. C., Christie, W. A., Carubia, B. A., & Geppert, C. (2022). Crossing state lines: Ethical and clinical considerations in treating a child with catatonia. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1016/j.jaac.2022.02.004CrossRef

Mukherjee, S., Bhattacharjee, A., Naha, S., Majumdar, T., Debbarma, S. K., Kaur, H., Dutta, S., & Basu, S. (2019). Molecular characterization of NDM-1-producing Klebsiella pneumoniae ST29, ST347, ST1224, and ST2558 causing sepsis in neonates in a tertiary care hospital of North-East India. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 69, 166–175. https://doi.org/10.1016/j.meegid.2019.01.024CrossRefPubMed

Oakley, B., Loth, E., & Murphy, D. G. (2021). Autism and mood disorders. International Review of Psychiatry (Abingdon, England), 33(3), 280–299. https://doi.org/10.1080/09540261.2021.1872506CrossRefPubMed

O’Halloran, L., Coey, P., & Wilson, C. (2022). Suicidality in autistic youth: A systematic review and meta-analysis. Clinical Psychology Review, 93, 102144. https://doi.org/10.1016/j.cpr.2022.102144CrossRefPubMed

Park, S. E., Grados, M., Wachtel, L., & Kaji, S. (2020). Use of electroconvulsive therapy in autism. Child and Adolescent Psychiatric Clinics of North America, 29(3), 455–465. https://doi.org/10.1016/j.chc.2020.03.003CrossRefPubMed

Paus, T., Castro-Alamancos, M. A., & Petrides, M. (2001). Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. The European Journal of Neuroscience, 14(8), 1405–1411. https://doi.org/10.1046/j.0953-816x.2001.01757.xCrossRefPubMed

Rojas, D. C. (2014). The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. Journal of Neural Transmission, 121(8), 891–905. https://doi.org/10.1007/s00702-014-1216-0ADSCrossRefPubMedPubMedCentral

Rojas, D. C., & Wilson, L. B. (2014). γ-band abnormalities as markers of autism spectrum disorders. Biomarkers in Medicine, 8(3), 353–368. https://doi.org/10.2217/bmm.14.15CrossRefPubMed

Russell, G., Mandy, W., Elliott, D., White, R., Pittwood, T., & Ford, T. (2019). Selection bias on intellectual ability in autism research: A cross-sectional review and meta-analysis. Molecular Autism, 10(1), 9. https://doi.org/10.1186/s13229-019-0260-xCrossRefPubMedPubMedCentral

Sackeim, H. A. (2017). Modern electroconvulsive therapy: Vastly improved yet greatly underused. JAMA Psychiatry, 74(8), 779–780. https://doi.org/10.1001/jamapsychiatry.2017.1670CrossRefPubMed

Schwartzman, J. M., Smith, J. R., & Bettis, A. H. (2021). Safety planning for suicidality in autism: Obstacles, potential solutions, and future directions. Pediatrics. https://doi.org/10.1542/peds.2021-052958CrossRefPubMed

Segers, M., & Rawana, J. (2014). What do we know about suicidality in autism spectrum disorders? A systematic review. Autism Research: Official Journal of the International Society for Autism Research, 7(4), 507–521. https://doi.org/10.1002/aur.1375CrossRefPubMed

Selimbeyoglu, A., Kim, C. K., Inoue, M., Lee, S. Y., Hong, A. S. O., Kauvar, I., Ramakrishnan, C., Fenno, L. E., Davidson, T. J., Wright, M., & Deisseroth, K. (2017). Modulation of prefrontal cortex excitation/inhibition balance rescues social behavior in CNTNAP2-deficient mice. Science Translational Medicine, 9(401), eaah6733. https://doi.org/10.1126/scitranslmed.aah6733CrossRefPubMedPubMedCentral

Shaw, K. A., McArthur, D., Hughes, M. M., Bakian, A. V., Lee, L.-C., Pettygrove, S., & Maenner, M. J. (2021). Progress and disparities in early identification of autism spectrum disorder: Autism and developmental disabilities monitoring network, 2002–2016. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1016/j.jaac.2021.11.019CrossRef

Singh, A., & Kar, S. K. (2017). How electroconvulsive therapy works?: Understanding the neurobiological mechanisms. Clinical Psychopharmacology and Neuroscience, 15(3), 210–221. https://doi.org/10.9758/cpn.2017.15.3.210CrossRefPubMedPubMedCentral

Sirgiovanni, E. (2021). Electroconvulsive therapy applications on children in the 1940s: The Italian case. The Journal of ECT, 37(3), 152–157. https://doi.org/10.1097/YCT.0000000000000758CrossRefPubMed

Smith, J. R., DiSalvo, M., Green, A., Ceranoglu, T. A., Anteraper, S. A., Croarkin, P., & Joshi, G. (2022). Treatment response of transcranial magnetic stimulation in intellectually capable youth and young adults with autism spectrum disorder: A systematic review and meta-analysis. Neuropsychology Review. https://doi.org/10.1007/s11065-022-09564-1CrossRefPubMed

Smith, J. R., & Pierce, D. L. (2022). Letter to the editor: Aripiprazole-induced hypersexuality in an autistic child. Journal of Child and Adolescent Psychopharmacology, 32(1), 70–71. https://doi.org/10.1089/cap.2021.0130CrossRefPubMed

Sokhadze, E. M., El-Baz, A. S., Baruth, J. M., Mathai, G., Sears, L. L., & Casanova, M. F. (2009). Effects of low frequency repetitive transcranial magnetic stimulation (rTMS) on gamma frequency oscillations and event-related potentials during processing of illusory figures in autism. Journal of Autism and Developmental Disorders, 39(4), 619–634. https://doi.org/10.1007/s10803-008-0662-7CrossRefPubMed

Stedman, A., Taylor, B., Erard, M., Peura, C., & Siegel, M. (2019). Are children severely affected by autism spectrum disorder underrepresented in treatment studies? An analysis of the literature. Journal of Autism and Developmental Disorders, 49(4), 1378–1390. https://doi.org/10.1007/s10803-018-3844-yCrossRefPubMed

Steullet, P., Cabungcal, J.-H., Coyle, J., Didriksen, M., Gill, K., Grace, A. A., Hensch, T. K., LaMantia, A.-S., Lindemann, L., Maynard, T. M., Meyer, U., Morishita, H., O’Donnell, P., Puhl, M., Cuenod, M., & Do, K. Q. (2017). Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia. Molecular Psychiatry, 22(7), 936. https://doi.org/10.1038/mp.2017.47CrossRefPubMedPubMedCentral

Tillmann, J., San JoséSáceres, A., Chatham, C. H., Crawley, D., Holt, R., Oakley, B., Banaschewski, T., Baron-Cohen, S., Bölte, S., Buitelaar, J. K., Durston, S., Ham, L., Loth, E., Simonoff, E., Spooren, W., Murphy, D. G., Charman, T., EU-AIMS LEAP group. (2019). Investigating the factors underlying adaptive functioning in autism in the EU-AIMS longitudinal European autism project. Autism Research: Official Journal of the International Society for Autism Research, 12(4), 645–657. https://doi.org/10.1002/aur.2081CrossRefPubMed

Tørring, N., Sanghani, S. N., Petrides, G., Kellner, C. H., & Østergaard, S. D. (2017). The mortality rate of electroconvulsive therapy: A systematic review and pooled analysis. Acta Psychiatrica Scandinavica, 135(5), 388–397. https://doi.org/10.1111/acps.12721CrossRefPubMed

van Waarde, J. A., Stolker, J. J., & van der Mast, R. C. (2001). ECT in mental retardation: A review. The Journal of ECT, 17(4), 236–243. https://doi.org/10.1097/00124509-200112000-00002CrossRefPubMed

Vandekar, S., Tao, R., & Blume, J. (2020). A robust effect size index. Psychometrika, 85(1), 232–246. https://doi.org/10.1007/s11336-020-09698-2MathSciNetCrossRefPubMedPubMedCentral

Vaquerizo-Serrano, J., de Pablo, G. S., Singh, J., & Santosh, P. (2021). Catatonia in autism spectrum disorders: A systematic review and meta-analysis. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.2259CrossRefPubMedPubMedCentral

Wachtel, L. E. (2019). Treatment of catatonia in autism spectrum disorders. Acta Psychiatrica Scandinavica, 139(1), 46–55. https://doi.org/10.1111/acps.12980CrossRefPubMed

Wachtel, L. E., Jaffe, R., & Kellner, C. H. (2011). Electroconvulsive therapy for psychotropic-refractory bipolar affective disorder and severe self-injury and aggression in an 11-year-old autistic boy. European Child & Adolescent Psychiatry, 20(3), 147–152. https://doi.org/10.1007/s00787-010-0155-zCrossRef

Wachtel, L. E., Shorter, E., & Fink, M. (2018). Electroconvulsive therapy for self-injurious behaviour in autism spectrum disorders: Recognizing catatonia is key. Current Opinion in Psychiatry, 31(2), 116–122. https://doi.org/10.1097/YCO.0000000000000393CrossRefPubMed

Walther, S., Stegmayer, K., Wilson, J. E., & Heckers, S. (2019). Structure and neural mechanisms of catatonia. The Lancet. Psychiatry, 6(7), 610–619. https://doi.org/10.1016/S2215-0366(18)30474-7CrossRefPubMedPubMedCentral

Wennström, M., Hellsten, J., Ekstrand, J., Lindgren, H., & Tingström, A. (2006). Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures. Biological Psychiatry, 59(2), 178–186. https://doi.org/10.1016/j.biopsych.2005.08.032CrossRefPubMed

Withane, N., & Dhossche, D. M. (2019). Electroconvulsive treatment for catatonia in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America, 28(1), 101–110. https://doi.org/10.1016/j.chc.2018.07.006CrossRefPubMed

Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., Fratiglioni, L., Jennum, P., Lieb, R., Maercker, A., van Os, J., Preisig, M., Salvador-Carulla, L., Simon, R., & Steinhausen, H.-C. (2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 21(9), 655–679. https://doi.org/10.1016/j.euroneuro.2011.07.018CrossRefPubMed

Wood, J. J., Kendall, P. C., Wood, K. S., Kerns, C. M., Seltzer, M., Small, B. J., Lewin, A. B., & Storch, E. A. (2020). Cognitive behavioral treatments for anxiety in children with autism spectrum disorder: A randomized clinical trial. JAMA Psychiatry, 77(5), 474–483. https://doi.org/10.1001/jamapsychiatry.2019.4160CrossRefPubMed

Zhou, M. S., Nasir, M., Farhat, L. C., Kook, M., Artukoglu, B. B., & Bloch, M. H. (2021). Meta-analysis: pharmacologic treatment of restricted and repetitive behaviors in autism spectrum disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 60(1), 35–45. https://doi.org/10.1016/j.jaac.2020.03.007CrossRef

Zolezzi, M. (2016). Medication management during electroconvulsant therapy. Neuropsychiatric Disease and Treatment, 12, 931–939. https://doi.org/10.2147/NDT.S100908CrossRefPubMedPubMedCentral

Titel: Use of ECT in Autism Spectrum Disorder and/or Intellectual Disability: A Single Site Retrospective Analysis
Auteurs: Joshua R. Smith
Corey E. Hopkins
Jiangmei Xiong
James Luccarelli
Elizabeth Shultz
Simon Vandekar
Publicatiedatum: 17-12-2022
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 3/2024
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-022-05868-6

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 3/2024

Implementation of a Peer-Mediated Intervention to Teach Behavioral Expectations for Two Students on Autism Spectrum and a Student with ADHD in an Inclusive Elementary Classroom in Taiwan

Factors Predicting Poor Mental and Physical Health in Parents of Children with Autism Spectrum Disorder: Results from 2016 to 2019 National Survey of Children’s Health

Setting Families Up for Success: A Pilot Study of a Toolkit to Enhance the Autism Spectrum Disorder Diagnostic Evaluation Process

Associations Between Parenting Stress and Quality Time in Families of Youth with Autism Spectrum Disorder

Publisher Correction to: Morphological Features of Language Regions in Individuals with Tuberous Sclerosis Complex

Psychometric Evaluation of the Autism Spectrum Rating Scales (6–18 Years Parent Report) in a Clinical Sample